What are SGLT-2 inhibitors?
Sodium glucose co-transporter inhibitors (SGLT-2) are sometimes known as ‘gliflozins’ e.g. canagliflozin (Invokana®), dapagliflozin (Forxiga®), empagliflozin (Jardiance®), ertugliflozin (Steglatro®). They are prescribed for type 2 diabetes, heart failure (weak pump function of the heart) or kidney disease. They can also be prescribed if you have one or more of these conditions
Please see leaflet attached for more information on SGLT-2s and a reminder on what to do if you should become unwell, including sick day rules, and the most common side effects.